Treatment Registry
TR-0379 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Mint Med · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$145

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Month-to-month, lifetime price, all doses included · recorded initial monthly payment$145

Added from the figures recorded below.

Price

TermPublished rateCharged today
Month-to-month, lifetime price, all doses included

“$145/month | Month-to-Month Lifetime Price (All Doses Included) Compounded Tirzepatide”

Per month$145Charged today$145
12 months prepaid, lifetime price, all doses included

“$125/month | Lifetime Price (All Doses Included) 12 Months Prepaid Compounded Tirzepatide”

$125Published figureCharged todayNot verified
Price sources
Visit Mint Med

We earn nothing from this link. It opens Mint Med's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

States36 states: Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming
PrescriberBoth
CancellationCancellation requests must be submitted at least 48 business hours before your next scheduled order processing date. Cancellations received within 48 business hours of the order processing date cannot be processed.

Not yet checked: pharmacy, membership and consult fee.

Recorded from mintmed.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Mint Med's own product pages contradict each other on price for the identical drug: the current collection listing prices compounded semaglutide at $106/mo (down to $86/mo on 12-month prepay) and compounded tirzepatide at $145/mo (down to $125/mo on 12-month prepay), but an older/parallel product page (compounded-semaglutide-month-to-month) prices the same compounded semaglutide at $246/mo, another (compounded-semaglutide-1) shows a $133/mo-then-$246/mo starter pack, and the how-it-works promo tile prices compounded tirzepatide at $299 (regular $499) instead of $145. Also a state-count mismatch: the homepage prose says 'Mint Med currently provides services in 35 U.S. states' but the state abbreviation list on the same page enumerates 36 distinct states.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0379
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from Mint Med

All Mint Med programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Mint Med — compounded tirzepatide (TR-0379). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0379

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.